BRK-B vs ITIC
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.
ITIC presents a contradictory profile characterized by a weak Piotroski F-Score of 3/9, indicating deteriorating fundamental health, despite an exceptionally clean balance sheet with a Debt/Equity ratio of 0.03. While the stock trades below its Graham Number ($243.61), suggesting defensive value, it sits significantly above its growth-based intrinsic value ($129.92) amid negative YoY revenue (-1.60%) and earnings growth (-10.10%). The technical trend is purely bearish (0/100), and the lack of analyst coverage suggests a neglected small-cap position. Overall, the company is financially stable but operationally stagnant.
Compare Another Pair
Related Comparisons
BRK-B vs ITIC: Head-to-Head Comparison
This page compares Berkshire Hathaway Inc. (BRK-B) and Investors Title Company (ITIC) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.